New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 14, 2013
05:46 EDTVNDAVanda Pharmaceuticals upgraded to Buy from Hold at Jefferies
Jefferies upgraded Vanda Pharmaceuticals citing positive sleep efficacy data for the company's tasimelteon drug. The firm raised its price target for shares to $6.00 from $3.50.
News For VNDA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for VNDA

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use